COMMUNIQUÉS West-GlobeNewswire

iMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress
09/06/2026
Multiple events and presentations will highlight potential benefits of in-house transplanted-organ-rejection testing, and of GraftAssure technology specifically Major transplantation conference in Boston will create [...]
Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL
09/06/2026
NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving [...]
Statement of Total Voting Rights and Shares Forming The Company’s Share Capital as of May 22, 2026
09/06/2026
Article R. 22-10-23 of the French Commercial Code Market : Euronext Paris ISIN code / Mnemo: FR0013233012 / IVA Web site: www.inventivapharma.com Date Number of Shares Outstanding Total Voting Rights, Gross (1) Total [...]
Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders
09/06/2026
TORONTO, June 09, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ( "Spectral" or the "Company" ) (TSX: EDT) , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced [...]
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/06/2026
RESEARCH TRIANGLE PARK, N.C., June 09, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted nine newly-hired [...]
Vireo Growth Inc. Appoints BDO as its New Auditor
09/06/2026
MINNEAPOLIS, June 09, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOD) (“Vireo” or the “Company”) today announced the appointment of BDO USA, P.C. (“BDO”) as the Company’s new independent registered [...]
TerrAscend Announces Results of Annual General Meeting
09/06/2026
TORONTO, June 09, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF) , a leading North American cannabis operator, today announced the results of its annual meeting of [...]
Assemblée Générale Mixte du 30 juin 2026 - Modalités de mise à disposition des documents préparatoires
09/06/2026
Daix (France), New York City (New York, United States), le 9 juin 2026 – Inventiva (Euronext Paris et Nasdaq : IVA ) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement d’une [...]
Combined General Meeting of June 30, 2026 - Availability of the Preparatory Documents
09/06/2026
Daix (France), New York City (New York, United States), June 9,2026 – Inventiva (Euronext Paris and NASDAQ: IVA ) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 mai 2026
09/06/2026
Nombre total de droits de vote et d’actions composant le capital social au 31 mai 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
AB Science présentera, lors du congrès annuel 2026 de l'ENCALS, les données de survie issues du programme clinique du masitinib dans la SLA
09/06/2026
COMMUNIQUÉ DE PRESSE AB SCIENCE PRÉSENTERA, LORS DU CONGRÈS ANNUEL 2026 DE L'ENCALS, LES DONNÉES DE SURVIE ISSUE DU PROGRAMME CLINIQUE DU MASITINIB DANS LA SCLÉROSE LATÉRALE AMYOTROPHIQUE Le traitement avec le masitinib [...]
AB Science is invited to present at the 2026 ENCALS annual meeting the survival data from masitinib clinical program in ALS
09/06/2026
PRESS RELEASE AB SCIENCE IS INVITED TO PRESENT AT THE 2026 ENCALS ANNUAL MEETING THE SURVIVAL DATA FROM MASITINIB CLINICAL PROGRAM IN AMYOTROPHIC LATERAL SCLEROSIS Masitinib treatment has been linked to a 5-year [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2026
09/06/2026
Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Applied Biologics Receives FDA Clearance to Advance BIOxHEAL Into Phase 3 Clinical Development for Diabetic Foot Ulcers
09/06/2026
SCOTTSDALE, Ariz., June 09, 2026 (GLOBE NEWSWIRE) -- Applied Biologics , a biopharmaceutical company developing novel biologic therapies for chronic wounds, tissue repair, and degenerative disease, today announced that [...]
AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules
09/06/2026
OCALA, Fla., June 09, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc . (NYSE American: AIM) (“AIM” or the “Company”), today announced that it has entered into definitive agreements for a registered direct offering and [...]
Press Release Biocartis NV: Biocartis Announces Agreement with City of Hope to Explore Development of Rapid Gene Signature Test for Early Detection of Pancreatic Cancer
09/06/2026
PRESS RELEASE, 06/09/2026, 08:00 CDT Biocartis Announces Agreement with City of Hope to Explore Development of Rapid Gene Signature Test for Early Detection of Pancreatic Cancer Itasca, IL, US, 09 June 2026 – Today, [...]
AMN Healthcare Acquires Jaide Health to Expand Language Access Across the Patient Journey Through AI Technology
09/06/2026
Acquisition strengthens end-to-end support for Limited English Proficiency (LEP) patients by pairing high-quality AI assistance with AMN’s trusted human interpreter services DALLAS, June 09, 2026 (GLOBE NEWSWIRE) -- AMN [...]
Legend Senior Living Earns Great Place to Work® Certification™ for Eighth Consecutive Year
09/06/2026
WICHITA, Kan., June 09, 2026 (GLOBE NEWSWIRE) -- Legend Senior Living ® has earned Great Place to Work ® Certification ™ for the eighth consecutive year, a distinction based entirely on feedback from associates through [...]
FDA Expands Sunscreen Options for the First Time in 20 Years
09/06/2026
Silver Spring, Md., June 09, 2026 (GLOBE NEWSWIRE) -- Today, the U.S. Food and Drug Administration added bemotrizinol to the list of permitted sunscreen active ingredients, marking a significant milestone in the agency' [...]

Pages